China approves Covid-19 vaccine for kids as young as 3 | World News - Hindustan Times
close_game
close_game

China approves Covid-19 vaccine for kids as young as 3

By | Written by Shivani Kumar | Edited by Amit Chaturvedi, Hindustan Times, New Delhi
Jun 06, 2021 09:16 AM IST

"When Sinovac's vaccine will be offered to younger groups depends on health authorities formulating China's inoculation strategies," local media reported Yin as saying.

China authorised the emergency use of Sinovac Biotech's coronavirus vaccine for children, becoming the first major country to do so for those as young as three. Until now, the immunisation drive was limited to people aged 18 and above.

Test tubes are seen in front of a displayed Sinovac logo in an illustration. (REUTERS/FILE)
Test tubes are seen in front of a displayed Sinovac logo in an illustration. (REUTERS/FILE)

In an official statement to state media, the company's chairman Yin Weidong announced the decision on Friday. The government is yet to announce an exact date when it will start administrating the jab to kids. "When Sinovac's vaccine will be offered to younger groups depends on health authorities formulating China's inoculation strategies," local media reported Yin as saying.

HT launches Crick-it, a one stop destination to catch Cricket, anytime, anywhere. Explore now!

The preliminary results from Phase I and II clinical trials show that the vaccine can trigger an immune response in kids. The adverse effects have been mild so far, news agency Reuters reported.

The participants were injected with a third booster dose after they completed their two regular shots. This resulted in 10-fold increase in antibody levels in a week, and 20-fold in half a month, Yin said while making the announcement.

It will continue to test a three-dose regimen and to observe antibody duration before the company actually makes the recommendation to authorities about when a third dose should be given, he added.

After Sinovac, state-backed drugmaker Sinopharm has also submitted a request for emergency approval for kids to the government. A vaccine from CanSino Biologics' is also in Phase II of the clinical trial involving those aged between six and 17.

Meanwhile, the vaccination drive in China accelerated in the country as authorities administered 100 million shots injust five days. Chinese public health officials said that they are aiming to inoculate 80% of the population of 1.4 billion by the end of the year.

(Agency inputs)

Discover the pivotal moments that shaped India's electoral journey on the Eras section of our exclusive Elections product. Access all content absolutely free on the HT App. Download now!

Get Latest World News, along with Latest News from India at Hindustan Times.
SHARE THIS ARTICLE ON
Share this article
SHARE
Story Saved
Live Score
OPEN APP
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Tuesday, April 23, 2024
Start 14 Days Free Trial Subscribe Now
Follow Us On